Nupam Mahajan, PhD

Medical School Department Surgery
Research Program Solid Tumor Therapeutics
Nupam Mahajan

Researcher Background

Primary Academic Title

Professor of Surgery, Endowed Professor of Urological Research, Division of Surgery, WashU Medicine

Education

  • 1997: PhD, Indian Institute of Science, Bangalore, India

Research & Selected Publications

Research Interest

Obtaining a fundamental understanding of various epigenetic events that a play crucial role in initiation and progression of prostate and beast cancer.

Research Publications

ACK1/TNK2 kinase: molecular mechanisms and emerging cancer therapeutics.
Authors:

Sridaran D, Mahajan NP

Journal & Year:

Trends Pharmacol Sci • 2025

SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis.
Authors:

Chouhan S, Sridaran D, Weimholt C, one or more additional authors omitted Mahajan NP

Journal & Year:

Nat Commun • 2024

Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppression.
Authors:

Angappulige DH, Mahajan NP, Mahajan K

Journal & Year:

Trends Cancer • 2024

Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach.
Authors:

Sridaran D, Bradshaw E, DeSelm C, one or more additional authors omitted Mahajan NP

Journal & Year:

Cell Rep Med • 2023